-
Q&A: Sandoz’s Schofield discusses blueprint for AmLactin brand
Since Sandoz acquired the AmLactin family of skin care brands from Upsher-Smith Laboratories last December, the company has been hammering out a growth strategy for the consumer skin care brand. With its strong heritage in the fast-expanding therapeutic segment of skin care, AmLactin offers rich potential for retailers to build that portion of their business. Brant Schofield, VP and general manager of dermatology at Sandoz, shared with Drug Store News the blueprint for AmLactin’s growth under Sandoz.